Table 2. Multivariate analysis related to survival using Cox regression.
Variables | OR | 95% CI | P | |
---|---|---|---|---|
Age | 0.98 | 0.95-1.01 | 0.24 | |
Female® Male |
- 1.04 |
- 0.37-2.92 |
- 0.92 |
|
Non-smoker® Smoker |
- 1.41 |
- 0.50-3.93 |
- 0.51 |
|
Squamous® Adenocarcinoma |
- 1.40 |
- 0.78-2.51 |
- 0.25 |
|
Tumor diameter | 1.17 | 1.01-1.35 | 0.031* | |
Tumor stage 1A® 1B 2A 2B 3A |
- 2.23 4.39 1.49 6.82 |
- 0.28-17.3 0.56-34.1 0.17-12.9 0.89-52.1 |
- 0.44 0.15 0.71 0.06 |
|
N0® N1 N2 |
- 1.47 2.79 |
- 0.74-2.94 1.36-5.74 |
- 0.26 0.005* |
|
Differentiation Poor® Moderate Well |
- 0.41 0.73 |
- 0.16-1.06 0.32-1.67 |
- 0.06 0.46 |
|
Lobectomy® Pneumonectomy |
- 1.57 |
- 0.75-3.26 |
- 0.22 |
|
Adjuvant therapy Given® Not given |
- 0.66 |
- 0.37-1,20 |
- 0.17 |
|
Nuclear topo2α Negative® Positive |
- 1.24 |
- 0.69-2.22 |
- 0.46 |
|
Cytoplasmic topo2α Negative® + ++ +++ |
- 1.04 1.97 1.28 |
- 0.49-1.22 0.86-4.47 0.57-2.90 |
- 0.90 0.10 0.54 |
®Reference category, *Statistically significant.